References
- Aroui S, Brahim S, Hamelin J, De Waard M, Bréard J, Kenani A. 2009. Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis. Apoptosis. 14:1352–1365.
- Cesbron Y, Shaheen U, Free P, Lévy R. 2015. TAT and HA2 facilitate cellular uptake of gold nanoparticles but do not lead to cytosolic localisation. PLoS One. 10:e0121683.
- Chen XC, Liu ST, Deme B, Cristiglio V, Marquardt D, Weller R, Rao P, Wang Y, Bradshaw J. 2017. Efficient internalization of TAT peptide in zwitterionic DOPC phospholipid membrane revealed by neutron diffraction. Biochim. Biophys. Acta. 1859:910–916.
- Golan M, Feinshtein V, David A. 2016. Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells. Eur J Pharm Biopharm. 109:103–112.
- Gao H, Ping Q, Gu Y. 2007. The implantable 5-fluorouracil-loaded poly(L-lactic acid) fibers prepared by wet-spinning from suspension. J Control Release. 118:325–332.
- Liou J, Liu B, Martin A, Huang Y, Chiang H, Lee H. 2012. Protein transduction in human cells is enhanced by cell-penetrating peptides fused with an endosomolytic HA2 sequence. Peptides. 37:273–284.
- Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. 2000. Tat peptide-derivatizedmagnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol. 18:410–414.
- Margus H, Padari K, Pooga M. 2012. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. Mol Ther. 20:525–533.
- Madani F, Lindberg S, Langel U, Futaki S, Graslund A. 2011. Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys. 2011:414729.
- Massodi I, Thomas E, Raucheer D. 2009. Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer. Molecules. 14:1999–2015.
- Meng S, Wei B, Xu R, Zhang K, Wang L, Zhang R, Li J. 2009. TAT peptidesmediated small interfering RNA delivery to Huh-7 cells and efficiently inhibited hepatitis C virus RNA replication. Intervirology. 52:135–140.
- Qin LY, Yan L, Zhang L, Jin YM, Zhao QH. 2013. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corana in polymeric micelles for enhanced intracellular doxorubirin delivery. Int J Pharm. 456:315–324.
- Yan C, Gu J, Jing H, Taishi J, Lee R. 2017. Tat tagged and folate modified N-succinyl-chitosan (Tat-Suc-FA) self-assembly nanoparticle for therapeutic delivery OGX-011 to A549 cells. Mol Pharmaceutics. 14:1898–1905.
- Zhao X, Wang J, Tao S, Ye T, Kong X, Ren L. 2016. In vivo bio-distribution and efficient tumor targeting of gelatin/silica nanoparticles for gene delivery. Nanoscale Res Lett. 11:195.
- Zhang L, Lu J, Jin Y, Qiu L. 2014. Folate-conjugated beta-cyclodextrin-based polymeric micelles with enhanced doxorubicin antitumor efficacy. Colloids Surf B Biointerfaces. 122:260–269.